Clinical relevance of sarcopenia in patients with cirrhosis

World Journal of Gastroenterology

Volumn 20, Issue 25, 2014, Pages 8061-8071

  Montano Loza, Aldo J ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Body composition; Cirrhosis; Liver transplantation; Lumbar skeletal muscle index; Malnutrition; Mortality; Prognosis; Sarcopenia

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALNUTRITION; MORBIDITY; OBESITY; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SARCOPENIA; SURVIVAL; ADVERSE EFFECTS; BODY COMPOSITION; COMPLICATION; DISEASE COURSE; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PREDICTIVE VALUE; PROCEDURES; TREATMENT OUTCOME; ASCITES; BODY COMPOSITION ASSESSMENT; BRAIN DISEASE; CARDIOVASCULAR PARAMETERS; CHILD PUGH SCORE; FUNCTIONAL STATUS; HEPATIC VENOUS PRESSURE GRADIENT; HYPOALBUMINEMIA; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER DYSFUNCTION; MALABSORPTION; MODEL FOR END STAGE LIVER DISEASE SCORE; MUSCLE ATROPHY; MUSCULARITY ASSESSMENT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLETHYSMOGRAPHY; REVIEW; SUBJECTIVE GLOBAL ASSESSMENT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

BODY COMPOSITION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALNUTRITION; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SARCOPENIA; TREATMENT OUTCOME;

ALBUMIN; CREATININE; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PREALBUMIN; PROPRANOLOL; SODIUM; TRANSFERRIN;

EID: 84904015429     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i25.8061     Document Type: Article

References (92)

1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851 [PMID: 18328931 DOI: 10.1016/S0140-6736(08)60383-9]
2. Ratib S, Fleming KM, Crooks CJ, Aithal GP, West J. 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study. J Hepatol 2014; 60: 282-289 [PMID: 24128415 DOI: 10.1016/ j.jhep.2013.09.027]
3. Johnson TM, Overgard EB, Cohen AE, DiBaise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013; 28: 15-29 [PMID: 23319353 DOI: 10.117 7/0884533612469027]
4. O'Brien A, Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008; 134: 1729-1740 [PMID: 18471550 DOI: 10.1053/j.gastro.2008.02.001]
5. Montano-Loza AJ. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients. Minerva Gastroenterol Dietol 2013; 59: 173-186 [PMID: 23831908]
6. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle 2012; 3: 225-237 [PMID: 22648736 DOI: 10.1007/s13539-012-0069-3]
7. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763 [PMID: 9554417]
8. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010; 21: 543-559 [PMID: 19779761 DOI: 10.1007/s00198-009-1059-y]
9. Lang PO, Michel JP, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009; 55: 539-549 [PMID: 19346741 DOI: 10.1159/000211949]
10. Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab 2010; 35: 707-712 [PMID: 20962927 DOI: 10.1139/ H10-067]
11. Durand F, Valla D. Assessment of prognosis of cirrhosis. Semin Liver Dis 2008; 28: 110-122 [PMID: 18293281 DOI: 10.1055/s-2008-1040325]
12. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128 [PMID: 3804191]
13. Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010; 32: 1343-1350 [PMID: 21050236 DOI: 10.1111/j.1365-2036.2010.04473.x]
14. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231 [PMID: 16298014]
15. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-1256, 1256. e1-5 [PMID: 20558165 DOI: 10.1053/j.gastro.2010.06.019]
16. Fede G, D'Amico G, Arvaniti V, Tsochatzis E, Germani G, Georgiadis D, Morabito A, Burroughs AK. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol 2012; 56: 810-818 [PMID: 22173162 DOI: 10.1016/ j.jhep.2011.10.016]
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649 [PMID: 4541913 DOI: 10.1002/bjs.1800600817]
18. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45: 797-805 [PMID: 17326206 DOI: 10.1002/hep.21563]
19. Child CG. Surgery and portal hypertension. In: Child CG, ed The Liver and Portal Hypertension Philadelphia. PA: WB Saunders, 1964: 50-72
20. Planas R, Ballesté B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, Santos J, Coll S, Morillas RM, Solà R. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004; 40: 823-830 [PMID: 15094231 DOI: 10.1016/j.jhep.2004.01.005]
21. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24: 269-276 [PMID: 2734585 DOI: 10.3109 /00365528909093045]
22. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871 [PMID: 10733541 DOI: 10.1053/ he.2000.5852]
23. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 [PMID: 11172350 DOI: 10.1053/jhep.2001.22172]
24. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, Meregaglia D, Nicolini A, Lubatti L, Riggio O. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494-500 [PMID: 11943420 DOI: 10.1016/S0168-8278(01)00309-9]
25. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-885 [PMID: 12740346 DOI: 10.1136/gut.52.6.879]
26. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004; 40: 897-903 [PMID: 15158328 DOI: 10.1016/ j.jhep.2004.02.010]
27. Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 2007; 46: 1138-1145 [PMID: 17668882 DOI: 10.1002/hep.21787]
28. Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, Turcotte J, Teperman L. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-858 [PMID: 12200791 DOI: 10.1053/jlts.2002.35927]
29. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96 [PMID: 12512033 DOI: 10.1053/gast.2003.50016]
30. Brown RS, Lake JR. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant 2005; 5: 203-204 [PMID: 15643978 DOI: 10.1111/j.1600-6143.2005.00769.x]
31. Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PJ. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9: 12-18 [PMID: 12514767 DOI: 10.1053/jlts.2003.50009]
32. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802-810 [PMID: 15382176]
33. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026 [PMID: 18768945 DOI: 10.1056/NEJMoa0801209]
34. Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One 2013; 8: e51926 [PMID: 23349678 DOI: 10.1371/journal. pone.0051926]
35. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-173, 173. e1 [PMID: 21893129 DOI: 10.1016/j.cgh.2011.08.028]
36. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481-488 [PMID: 17681169]
37. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, Douglas DD. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl 2010; 16: 1373-1378 [PMID: 21117246 DOI: 10.1002/lt.22167]
38. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008; 28: 606-613 [PMID: 18433390 DOI: 10.1111/j.1478-3231.2008.01727.x]
39. DiCecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, Krom RA. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc 1989; 64: 95-102 [PMID: 2492064]
40. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012; 16: 95-131 [PMID: 22321468 DOI: 10.1016/j.cld.2011.12.009]
41. Montano-Loza AJ, Meza-Junco J, Prado CMM, Sawyer MB, Ma M, Beaumont C, Esfandiari N, Kneteman N, Baracos VE. Sarcopenic obesity and muscle fat infiltration are associated with higher mortality in patients with cirrhosis. Hepatology 2013; 58 Suppl: 865A
42. Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewell J, Langer B, Jeejeebhoy KN. Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982; 306: 969-972 [PMID: 6801515 DOI: 10.1056/NEJM198204223061606]
43. Fernandes SA, Bassani L, Nunes FF, Aydos ME, Alves AV, Marroni CA. Nutritional assessment in patients with cirrhosis. Arq Gastroenterol 2012; 49: 19-27 [PMID: 22481682]
44. Hasse J, Strong S, Gorman MA, Liepa G. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993; 9: 339-343 [PMID: 8400590]
45. O'Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 1980; 2: 615-617 [PMID: 6107408 DOI: 10.1016/S0140-6736(80)90284-6]
46. Sobhonslidsuk A, Roongpisuthipong C, Nantiruj K, Kulapongse S, Songchitsomboon S, Sumalnop K, Bussagorn N. Impact of liver cirrhosis on nutritional and immunological status. J Med Assoc Thai 2001; 84: 982-988 [PMID: 11759979]
47. Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for endstage liver disease score. Liver Transpl 2010; 16: 1169-1177 [PMID: 20879015 DOI: 10.1002/lt.22128]
48. Akerman PA, Jenkins RL, Bistrian BR. Preoperative nutrition assessment in liver transplantation. Nutrition 1993; 9: 350-356 [PMID: 8400592]
49. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 1996; 23: 1041-1046 [PMID: 8621131 DOI: 10.1002/hep.510230516]
50. Gunsar F, Raimondo ML, Jones S, Terreni N, Wong C, Patch D, Sabin C, Burroughs AK. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006; 24: 563-572 [PMID: 16827812 DOI: 10.1111/j.1365-2036.2006.03003.x]
51. Abad-Lacruz A, Cabré E, González-Huix F, Fernández-Bañares F, Esteve M, Planas R, Llovet JM, Quer JC, Gassull MA. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993; 88: 382-387 [PMID: 8438845]
52. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005; 21: 113-117 [PMID: 15723736 DOI: 10.1016/ j.nut.2004.02.002]
53. Figueiredo FA, De Mello Perez R, Kondo M. Effect of liver cirrhosis on body composition: evidence of significant depletion even in mild disease. J Gastroenterol Hepatol 2005; 20: 209-216 [PMID: 15683423 DOI: 10.1111/j.1440-1746.2004.03544.x]
54. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007; 85: 1257-1266 [PMID: 17490961]
55. Carvalho L, Parise ER. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006; 43: 269-274 [PMID: 17406753 DOI: 10.1590/ S0004-28032006000400005]
56. Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol 1992; 65: 895-900 [PMID: 1422663 DOI: 10.1259/0007-1285-65-778-895]
57. Pirlich M, Schütz T, Spachos T, Ertl S, Weiss ML, Lochs H, Plauth M. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32: 1208-1215 [PMID: 11093726 DOI: 10.1053/jhep.2000.20524]
58. Madden AM, Morgan MY. The potential role of dual-energy X-ray absorptiometry in the assessment of body composition in cirrhotic patients. Nutrition 1997; 13: 40-45 [PMID: 9058447 DOI: 10.1016/S0899-9007(97)90877-7]
59. Morgan MY, Madden AM, Jennings G, Elia M, Fuller NJ. Two-component models are of limited value for the assessment of body composition in patients with cirrhosis. Am J Clin Nutr 2006; 84: 1151-1162 [PMID: 17093169]
60. Fiore P, Merli M, Andreoli A, De Lorenzo A, Masini A, Ciuffa L, Valeriano V, Balotta MT, Riggio O. A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999; 18: 349-351 [PMID: 10634919 DOI: 10.1016/ S0261-5614(99)80014-4]
61. Biaggi RR, Vollman MW, Nies MA, Brener CE, Flakoll PJ, Levenhagen DK, Sun M, Karabulut Z, Chen KY. Comparison of air-displacement plethysmography with hydrostatic weighing and bioelectrical impedance analysis for the assessment of body composition in healthy adults. Am J Clin Nutr 1999; 69: 898-903 [PMID: 10232628]
62. Dempster P, Aitkens S. A new air displacement method for the determination of human body composition. Med Sci Sports Exerc 1995; 27: 1692-1697 [PMID: 8614327 DOI: 10.124 9/00005768-199512000-00017]
63. Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994; 57: 469-472 [PMID: 8108888]
64. Glass C, Hipskind P, Tsien C, Malin SK, Kasumov T, Shah SN, Kirwan JP, Dasarathy S. Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study. J Appl Physiol (1985) 2013; 114: 559-565 [PMID: 23288550 DOI: 10.1152/japplphysiol. 01042.2012]
65. Heymsfield SB. Development of imaging methods to assess adiposity and metabolism. Int J Obes (Lond) 2008; 32 Suppl 7: S76-S82 [PMID: 19136995 DOI: 10.1038/ijo.2008.242]
66. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) 1998; 85: 115-122 [PMID: 9655763]
67. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997-1006 [PMID: 18923576 DOI: 10.1139/H08-075]
68. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-635 [PMID: 18539529 DOI: 10.1016/S1470-2045(08)70153-0]
69. Montano-Loza AJ, Meza-Junco J, Prado CMM, Tandon P, Bain VG, Ma M, Beaumont C, Esfandiari N, Sawyer MB, Baracos VE. New cutoff values for sarcopenia for predicting 6-months mortality in cirrhotic patients. J Hepatol 2013; 58: S95
70. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR, Sawyer MB. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013; 47: 861-870 [PMID: 23751844 DOI: 10.1097/MCG.0b013e318293a825]
71. Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12: 3380-3385 [PMID: 16733855]
72. Møller S, Bendtsen F, Christensen E, Henriksen JH. Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol 1994; 21: 940-946 [PMID: 7699257]
73. Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V, Lattanzi B, Riggio O. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis 2013; 28: 281-284 [PMID: 23224378 DOI: 10.1007/s11011-012-9365-z]
74. Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R, Björnsson E. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int 2007; 27: 1194-1201 [PMID: 17919230]
75. Sörös P, Böttcher J, Weissenborn K, Selberg O, Müller MJ. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study. J Gastroenterol Hepatol 2008; 23: 606-610 [PMID: 18005013]
76. Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010; 8: 979-985 [PMID: 20621200 DOI: 10.1016/j.cgh.2010.06.024]
77. Vaisman N, Katzman H, Carmiel-Haggai M, Lusthaus M, Niv E. Breakfast improves cognitive function in cirrhotic patients with cognitive impairment. Am J Clin Nutr 2010; 92: 137-140 [PMID: 20444959 DOI: 10.3945/ajcn.2010.29211]
78. Khanna S, Gopalan S. Role of branched-chain amino acids in liver disease: the evidence for and against. Curr Opin Clin Nutr Metab Care 2007; 10: 297-303 [PMID: 17414498]
79. Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr Opin Gastroenterol 2011; 27: 174-179 [PMID: 20975555 DOI: 10.1097/MOG.0b013e3283409c25]
80. Drummond MJ, Rasmussen BB. Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis. Curr Opin Clin Nutr Metab Care 2008; 11: 222-226 [PMID: 18403916 DOI: 10.1097/MCO.0b013e3282fa17fb]
81. Dreyer HC, Drummond MJ, Pennings B, Fujita S, Glynn EL, Chinkes DL, Dhanani S, Volpi E, Rasmussen BB. Leucineenriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscle. Am J Physiol Endocrinol Metab 2008; 294: E392-E400 [PMID: 18056791]
82. García-Pagàn JC, Santos C, Barberá JA, Luca A, Roca J, Rodriguez-Roisin R, Bosch J, Rodés J. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996; 111: 1300-1306 [PMID: 8898644]
83. Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, Bosch J. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 1998; 28: 677-682 [PMID: 9731558]
84. Tsien C, Shah SN, McCullough AJ, Dasarathy S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol 2013; 25: 85-93 [PMID: 23011041 DOI: 10.1097/MEG.0b013e328359a759]
85. Montano-Loza AJ, Meza-Junco J, Baracos VE, Tandon P, Bain VG, Ma M, Beaumont C, Esfandiari N, Sawyer MB, Kneteman N. Muscle wasting is not associated with higher mortality after liver transplantation. Hepatology 2012; 56 Suppl: 651A
86. García PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth Analg 2010; 111: 707-709 [PMID: 20686014 DOI: 10.1213/ANE.0b013e3181eac1c9]
87. Dasarathy S, McCullough AJ, Muc S, Schneyer A, Bennett CD, Dodig M, Kalhan SC. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol 2011; 54: 915-921 [PMID: 21145817 DOI: 10.1016/j.jhep.2010.08.032]
88. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, Holcombe SA, Wang SC, Segev DL, Sonnenday CJ. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278 [PMID: 20670867 DOI: 10.1016/ j.jamcollsurg.2010.03.039]
89. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 2004; 97: 2333-2338 [PMID: 15310748]
90. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445-450 [PMID: 11399401]
91. Fukushima K, Ueno Y, Kawagishi N, Kondo Y, Inoue J, Kakazu E, Ninomiya M, Wakui Y, Saito N, Satomi S, Shimosegawa T. The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases. Tohoku J Exp Med 2011; 224: 215-219 [PMID: 21701127 DOI: 10.1620/tjem.224.215]
92. Montano-Loza AJ, Meza-Junco J, Prado CMM, Baracos VE, Sawyer MB, Ma M, Kneteman N, Myers RP. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Hepatology 2013; 58 Suppl: 1041A